P/E ratio for InspireMD (NSPR)
P/E ratio as of April 2025 (TTM): -1.31
According to InspireMD's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.30903. At the end of 2022 the company had a P/E ratio of -0.3675.
P/E ratio history for InspireMD from 2011 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.3675 | -75.05% |
| 2021 | -1.47 | 241.23% |
| 2020 | -0.4317 | 189.41% |
| 2019 | -0.1492 | 24.24% |
| 2018 | -0.1201 | 3650.8% |
| 2017 | -0.0032 | -41.61% |
| 2016 | -0.0055 | -52.92% |
| 2015 | -0.0116 | -61.31% |
| 2014 | -0.0301 | -59.41% |
| 2013 | -0.0741 | |
| 2011 | -0.2230 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.